161 related articles for article (PubMed ID: 38834656)
1. Parallel detection of multiple biomarkers in a point-of-care-competent device for the prediction of exacerbations in chronic inflammatory lung disease.
Röckendorf N; Ramaker K; Gaede K; Tappertzhofen K; Lunding L; Wegmann M; Horbert P; Weber K; Frey A
Sci Rep; 2024 Jun; 14(1):12830. PubMed ID: 38834656
[TBL] [Abstract][Full Text] [Related]
2. Study of inflammatory biomarkers in COPD and asthma exacerbations.
Vassiliou AG; Vitsas V; Kardara M; Keskinidou C; Michalopoulou P; Rovina N; Dimopoulou I; Orfanos SE; Tsoukalas G; Koutsoukou A; Kotanidou A
Adv Respir Med; 2020; 88(6):558-566. PubMed ID: 33393648
[TBL] [Abstract][Full Text] [Related]
3. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
4. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.
Sethi S; Wrona C; Eschberger K; Lobbins P; Cai X; Murphy TF
Am J Respir Crit Care Med; 2008 Mar; 177(5):491-7. PubMed ID: 18079493
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.
Gallego M; Pomares X; Capilla S; Marcos MA; Suárez D; Monsó E; Montón C
Int J Chron Obstruct Pulmon Dis; 2016; 11():2633-2640. PubMed ID: 27799762
[TBL] [Abstract][Full Text] [Related]
7. Electrochemical methods for detection of biomarkers of Chronic Obstructive Pulmonary Disease in serum and saliva.
Chen X; Dong T; Wei X; Yang Z; Matos Pires NM; Ren J; Jiang Z
Biosens Bioelectron; 2019 Oct; 142():111453. PubMed ID: 31295711
[TBL] [Abstract][Full Text] [Related]
8. A two-stage logistic model based on the measurement of pro-inflammatory cytokines in bronchial secretions for assessing bacterial, viral, and non-infectious origin of COPD exacerbations.
Dal Negro RW; Micheletto C; Tognella S; Visconti M; Guerriero M; Sandri MF
COPD; 2005 Mar; 2(1):7-16. PubMed ID: 17136956
[TBL] [Abstract][Full Text] [Related]
9. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive biomarkers in exacerbations of obstructive lung disease.
Warwick G; Thomas PS; Yates DH
Respirology; 2013 Jul; 18(5):874-84. PubMed ID: 23521049
[TBL] [Abstract][Full Text] [Related]
11. Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease.
Baines KJ; Fu JJ; McDonald VM; Gibson PG
Int J Chron Obstruct Pulmon Dis; 2017; 12():541-550. PubMed ID: 28223794
[TBL] [Abstract][Full Text] [Related]
12. Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens.
Kawamatawong T; Apiwattanaporn A; Siricharoonwong W
Int J Chron Obstruct Pulmon Dis; 2017; 12():1625-1630. PubMed ID: 28615935
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.
Antonescu-Turcu AL; Tomic R
Curr Opin Pulm Med; 2009 Mar; 15(2):120-5. PubMed ID: 19532026
[TBL] [Abstract][Full Text] [Related]
14. Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD.
Fu JJ; McDonald VM; Baines KJ; Gibson PG
Chest; 2015 Sep; 148(3):618-629. PubMed ID: 25950204
[TBL] [Abstract][Full Text] [Related]
15. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
[TBL] [Abstract][Full Text] [Related]
16. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
[TBL] [Abstract][Full Text] [Related]
17. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC
Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.
Francis NA; Gillespie D; White P; Bates J; Lowe R; Sewell B; Phillips R; Stanton H; Kirby N; Wootton M; Thomas-Jones E; Hood K; Llor C; Cals J; Melbye H; Naik G; Gal M; Fitzsimmons D; Alam MF; Riga E; Cochrane A; Butler CC
Health Technol Assess; 2020 Mar; 24(15):1-108. PubMed ID: 32202490
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.
Karadag F; Karul AB; Cildag O; Yilmaz M; Ozcan H
Lung; 2008; 186(6):403-9. PubMed ID: 18807087
[TBL] [Abstract][Full Text] [Related]
20. Associations of the Serum KL-6 with Severity and Prognosis in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Wang Y; Fei J; Xu J; Cheng ZY; Ma YC; Wu JH; Yang J; Zhao H; Fu L
Lung; 2024 Jun; 202(3):245-255. PubMed ID: 38743087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
